MXPA03001920A - Tratamiento de trastornos inflamatorios. - Google Patents
Tratamiento de trastornos inflamatorios.Info
- Publication number
- MXPA03001920A MXPA03001920A MXPA03001920A MXPA03001920A MXPA03001920A MX PA03001920 A MXPA03001920 A MX PA03001920A MX PA03001920 A MXPA03001920 A MX PA03001920A MX PA03001920 A MXPA03001920 A MX PA03001920A MX PA03001920 A MXPA03001920 A MX PA03001920A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- inflammatory disorders
- inflammatory
- mefloquine
- administration
- Prior art date
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 229960001962 mefloquine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0021776.0A GB0021776D0 (en) | 2000-09-05 | 2000-09-05 | The treatment of inflammatory disorders |
| PCT/GB2001/003924 WO2002019994A2 (en) | 2000-09-05 | 2001-08-31 | The treatment of inflammatory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001920A true MXPA03001920A (es) | 2004-02-12 |
Family
ID=9898880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001920A MXPA03001920A (es) | 2000-09-05 | 2001-08-31 | Tratamiento de trastornos inflamatorios. |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7034028B2 (es) |
| EP (1) | EP1315496B1 (es) |
| JP (1) | JP2004508323A (es) |
| CN (1) | CN1309388C (es) |
| AT (1) | ATE302008T1 (es) |
| AU (2) | AU8423401A (es) |
| BR (1) | BR0113646A (es) |
| CA (1) | CA2419601A1 (es) |
| DE (1) | DE60112768T2 (es) |
| DK (1) | DK1315496T3 (es) |
| ES (1) | ES2245372T3 (es) |
| GB (1) | GB0021776D0 (es) |
| HK (1) | HK1054324A1 (es) |
| HU (1) | HUP0300934A2 (es) |
| IL (1) | IL154419A0 (es) |
| MX (1) | MXPA03001920A (es) |
| NO (1) | NO323227B1 (es) |
| NZ (1) | NZ524099A (es) |
| PL (1) | PL364030A1 (es) |
| PT (1) | PT1315496E (es) |
| WO (1) | WO2002019994A2 (es) |
| ZA (1) | ZA200301139B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0021776D0 (en) * | 2000-09-05 | 2000-10-18 | Arakis Ltd | The treatment of inflammatory disorders |
| GB0406014D0 (en) * | 2004-03-17 | 2004-04-21 | Arakis Ltd | Pharmaceutical composition and use |
| WO2006108666A1 (en) * | 2005-04-13 | 2006-10-19 | Proteosys Ag | Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases |
| EP2114397A4 (en) * | 2006-12-20 | 2013-06-12 | Medwell Lab Ltd | NOVEL CONJUGATES OF POLY-UNSATURATED FATTY ACIDS WITH AMINES AND THERAPEUTIC USES THEREOF |
| RU2013105255A (ru) * | 2010-07-07 | 2014-08-20 | Полимедикс, Инк. | Способы иммуномодуляции |
| CN113578299B (zh) * | 2020-04-30 | 2023-11-10 | 中国石油化工股份有限公司 | 一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用 |
| CN114452289B (zh) * | 2020-12-31 | 2023-06-09 | 兰州大学 | 喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用 |
| CN114796216A (zh) * | 2022-01-04 | 2022-07-29 | 南京医科大学 | 甲氟喹在防治全身代谢性炎症疾病中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0422097B1 (en) | 1988-06-30 | 1994-04-27 | DAVIS, Michael H. | Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo |
| CZ285937B6 (cs) * | 1992-01-16 | 1999-12-15 | Hoechst Aktiengesellschaft | Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití |
| KR100200449B1 (ko) * | 1994-03-09 | 1999-06-15 | 디. 제이. 우드, 스피겔 알렌 제이 | Tnf 방출 억제제로서의 이소옥사졸린 화합물 |
| AU730818B2 (en) | 1997-03-07 | 2001-03-15 | Vernalis Research Limited | Use of (+)mefloquine for the treatment of malaria |
| WO1999026627A1 (en) * | 1997-11-26 | 1999-06-03 | Cerebrus Limited | (-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders |
| EP1175216A2 (en) | 1999-04-30 | 2002-01-30 | APT Pharmaceutical, L.L.C. | Antimalarian agents for the treatment of asthma |
| GB0021776D0 (en) * | 2000-09-05 | 2000-10-18 | Arakis Ltd | The treatment of inflammatory disorders |
-
2000
- 2000-09-05 GB GBGB0021776.0A patent/GB0021776D0/en not_active Ceased
-
2001
- 2001-08-31 DK DK01963202T patent/DK1315496T3/da active
- 2001-08-31 AU AU8423401A patent/AU8423401A/xx active Pending
- 2001-08-31 WO PCT/GB2001/003924 patent/WO2002019994A2/en active IP Right Grant
- 2001-08-31 AT AT01963202T patent/ATE302008T1/de not_active IP Right Cessation
- 2001-08-31 ES ES01963202T patent/ES2245372T3/es not_active Expired - Lifetime
- 2001-08-31 US US10/362,784 patent/US7034028B2/en not_active Expired - Fee Related
- 2001-08-31 DE DE60112768T patent/DE60112768T2/de not_active Expired - Fee Related
- 2001-08-31 MX MXPA03001920A patent/MXPA03001920A/es active IP Right Grant
- 2001-08-31 EP EP01963202A patent/EP1315496B1/en not_active Expired - Lifetime
- 2001-08-31 IL IL15441901A patent/IL154419A0/xx unknown
- 2001-08-31 CA CA002419601A patent/CA2419601A1/en not_active Abandoned
- 2001-08-31 BR BR0113646-1A patent/BR0113646A/pt not_active IP Right Cessation
- 2001-08-31 CN CNB018152023A patent/CN1309388C/zh not_active Expired - Fee Related
- 2001-08-31 JP JP2002524479A patent/JP2004508323A/ja active Pending
- 2001-08-31 PT PT01963202T patent/PT1315496E/pt unknown
- 2001-08-31 NZ NZ524099A patent/NZ524099A/en unknown
- 2001-08-31 HU HU0300934A patent/HUP0300934A2/hu unknown
- 2001-08-31 PL PL01364030A patent/PL364030A1/xx not_active Application Discontinuation
- 2001-08-31 AU AU2001284234A patent/AU2001284234B2/en not_active Ceased
-
2003
- 2003-02-11 ZA ZA200301139A patent/ZA200301139B/en unknown
- 2003-03-03 NO NO20030985A patent/NO323227B1/no unknown
- 2003-09-03 HK HK03106286A patent/HK1054324A1/xx not_active IP Right Cessation
-
2005
- 2005-11-30 US US11/290,944 patent/US20060074106A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60112768D1 (de) | 2005-09-22 |
| WO2002019994A2 (en) | 2002-03-14 |
| BR0113646A (pt) | 2004-01-06 |
| AU8423401A (en) | 2002-03-22 |
| ATE302008T1 (de) | 2005-09-15 |
| IL154419A0 (en) | 2003-09-17 |
| US20040029916A1 (en) | 2004-02-12 |
| DK1315496T3 (da) | 2005-11-14 |
| CN1309388C (zh) | 2007-04-11 |
| CN1452488A (zh) | 2003-10-29 |
| AU2001284234B2 (en) | 2004-11-04 |
| ZA200301139B (en) | 2004-03-29 |
| WO2002019994A3 (en) | 2002-05-16 |
| HK1054324A1 (en) | 2003-11-28 |
| NZ524099A (en) | 2004-04-30 |
| DE60112768T2 (de) | 2006-02-02 |
| PT1315496E (pt) | 2005-11-30 |
| NO20030985D0 (no) | 2003-03-03 |
| EP1315496A2 (en) | 2003-06-04 |
| US20060074106A1 (en) | 2006-04-06 |
| ES2245372T3 (es) | 2006-01-01 |
| JP2004508323A (ja) | 2004-03-18 |
| US7034028B2 (en) | 2006-04-25 |
| GB0021776D0 (en) | 2000-10-18 |
| HUP0300934A2 (hu) | 2003-11-28 |
| PL364030A1 (en) | 2004-12-13 |
| NO323227B1 (no) | 2007-02-05 |
| NO20030985L (no) | 2003-03-03 |
| EP1315496B1 (en) | 2005-08-17 |
| CA2419601A1 (en) | 2002-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2004003026A0 (en) | Methods for treating ocular neovascular diseases. | |
| PL362690A1 (en) | Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders | |
| HRP20020593B1 (en) | Brain, spinal and nerve injury treatment | |
| MXPA03002814A (es) | Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias. | |
| AU5093399A (en) | Hemofiltration systems, methods, and devices used to treat inflammatory mediatorrelated disease | |
| IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
| MXPA03002813A (es) | Compuestos utiles en el tratamiento de enfermedades inflamatorias. | |
| HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
| HK1041880A1 (en) | Compounds and methods for treatment of asthma, allergy and inflammatory disorders. | |
| MXPA03003741A (es) | Metodos y composiciones para el tratamiento de enfermedades oftalmicas. | |
| AU8423401A (en) | The treatment of inflammatory disorders | |
| HK1051692A1 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain. | |
| EP1229973A4 (en) | SWING FOR THE DISABLED | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| MXPA01011720A (es) | 3-piridil-4-arilpirroles sustituidos, y metodos terapeuticos y profilacticos relacionados. | |
| MXPA03003032A (es) | Terapia de combinacion para el tratamiento de una enfermedad sensible a los estrogenos. | |
| DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
| PT1212119E (pt) | Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas | |
| EP1409041A4 (en) | HEMOFILTRATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION MEDIATORS | |
| WO2000051585A3 (en) | Use of a non-naturally-occurring ep1 selective agonist for increasing bone volume | |
| NZ517348A (en) | Use of a mycobacterial extract in the treatment of inflammatory bowel disease | |
| AP2000001958A0 (en) | Paroxetine 10-camphorsulfornate for treatment of CNS disorders. | |
| 木村留美子 et al. | The influence of experience on nurse self-evaluation, in the context of self-imag ePart1 | |
| ZA200304439B (en) | Therapeutic treatment. | |
| AU5994699A (en) | Optimized use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |